Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed in the United States. It is testing Safety and Efficacy of SAGE-547 for depression.
In United StatesThis study is completed in the United States, in Bulgaria, in Hungary, .... It is testing CVL-231 (Emraclidine) for schizophrenia.
In United StatesThis study is completed in the United States. It is testing SAGE-217 for depression.
In United StatesThis study is completed in the United States. It is testing SAGE-547 for depression.
In United States
This study is completed in the United States. It is testing Sleep Electroencephalogram (EEG) Features (Brain Activity While Sleeping) for depression.
In United StatesThis study is completed in the United States. It is testing Abuse Potential of EB-1020 Immediate-Release for ADHD.
In United StatesThis study is completed in the United States. It focuses on Addiction.
In United StatesThis study is completed in the United States. It is testing Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia.
In United StatesThis study is completed in the United States, in France, in Bulgaria, .... It is testing Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo for Bipolarity.
Remote / onlineThis study is completed in the United States. It is testing effects of Basmisanil for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Effects of Once Daily Doses of AQW051 on Cognition, for schizophrenia.
In United StatesThis study is completed in the United States. It is testing Effects of RO5545965 for schizophrenia.
In United StatesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.